本页面由Tiger Trade Technology Pte. Ltd.提供服务

PMV Pharmaceuticals

1.19
-0.0900-7.03%
盘后1.230.0395+3.32%19:31 EST
成交量:48.69万
成交额:59.59万
市值:6,332.17万
市盈率:-0.75
高:1.31
开:1.31
低:1.18
收:1.28
52周最高:1.84
52周最低:0.8100
股本:5,321.15万
流通股本:3,620.46万
量比:1.78
换手率:1.34%
股息:- -
股息率:- -
每股收益(TTM):-1.5845
每股收益(LYR):-1.1382
净资产收益率:-51.87%
总资产收益率:-32.02%
市净率:0.52
市盈率(LYR):-1.05

数据加载中...

2024/06/07

重要事件披露

Form 8-K - Current report
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/01

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/01

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/01/23

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/19

重要事件披露

Form 8-K - Current report
2024/01/05

重要事件披露

Form 8-K - Current report
2023/11/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/10/13

重要事件披露

Form 8-K - Current report